Telix Pharmaceuticals Limited: Telix Accelerates Artificial

MELBOURNE, Australia, April 26, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability

Related Keywords

United Kingdom , United States , Switzerland , Australia , Japan , Vienna , Wien , Austria , Canada , Melbourne , Victoria , Belgium , Australian , Thomas Beyer , Mark Europe , Dedicaid Gmbh , Michael Wheatcroft , Linkedin , University Vienna , Health Canada , Drug Administration , Australian Therapeutic Goods Administration , Telix Pharmaceuticals , Australian Securities Exchange , Head Of The Research Domain Quantitative Imaging , Telix Pharmaceuticals Limited Disclosure Committee , Prnewswire Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Vienna Based Dedicaid Gmbh , Medical University , Medical University Vienna , United States Food , Chief Scientist , Research Domain , Quantitative Imaging , Medical Physics , Listing Rule , Telix Pharmaceuticals Limited , Nucl Med , Telix , Pharmaceuticals , Imited , Ccelerates , Rtificial , Intelligence , Development , Program , Cquisition , Medicaid ,